-
-
-
-
-
-
-
Health Catalyst Inc. (HCAT) PT Lowered to $2 at Canaccord
-
-
-
-
-
-
-
Health Catalyst's (HCAT) Still a 'Superior Technology Platform' - Cantor Fitzgerald
-
-
-
-
-
-
-
Piper Sandler Downgrades Health Catalyst Inc. (HCAT) to Neutral
-
-
-
-
-
-
-
Stifel Reiterates Hold Rating on Health Catalyst Inc. (HCAT)
-
-
-
-
-
-
-
Given contract opportunity Caid stocks likely undervalued, says Cantor Fitzgerald
-
-
-
-
-
-
-
Health Catalyst Inc. (HCAT) PT Lowered to $7 at RBC Capital
-
-
-
-
-
-
-
Canaccord Genuity Reiterates Buy Rating on Health Catalyst Inc. (HCAT)
-
483,106 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


